Skip to main content
. 2020 Dec 25;29(3):1047–1056. doi: 10.1016/j.ymthe.2020.12.028

Figure 3.

Figure 3

PCSK9 and LDL Serum Levels at Different Time Points Post-AAV

(A-F) Here, we show serum PCSK9 (A-D) and LDL (E and F) levels as a percentage of baseline. AAV vector and NHP identification number for each group are displayed on top. An asterisk (∗) indicates statistically significant averages (day 56 and until last time point) with respect to average levels pre-AAV dosage (p < 0.05, one-sided one-sample t test).